Gilead Sciences
Search results
We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables.
1 day ago · Swastika Investmart Ltd. Emcure Pharmaceuticals is a well-known participant in both the domestic and global pharmaceutical industries, according to the brokerage. The firm has a robust R&D ...
1 day ago · In fiscal year 2023-24 (FY24), Emcure Pharmaceuticals Limited recorded a revenue growth of 11.33 per cent, amounting to Rs 6,715 crore compared to Rs 6,031 crore in FY23. However, the company's profit after tax (PAT) declined by 6.1 per cent to Rs 527 crore in FY24 from Rs 561 crore in FY23. Emcure Pharma IPO share allotment.
3 days ago · 2) What is the industry overview of Emcure Pharmaceuticals? The global pharmaceutical market is expected to sustain growth at a compound annual growth rate of approximately 5.0% to 5.5% between the calendar years 2023 and 2028, to reach approximately $1,900 billion (approximately Rs 157 lakh crore) to $1,950 billion (about Rs 161 trillion) in the calendar year 2028.
Emcure Pharmaceuticals is a fast-growing Indian pharmaceutical company engaged in developing, manufacturing & marketing a broad range of pharmaceutical products globally.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical company with a differentiated product portfolio. With its wide range of offerings, Emcure Pharmaceuticals has cemented its presence in over 70 countries around the world.
2 days ago · IPO: Emcure Pharmaceuticals. All you need to know about the IPO of this generic pharmaceutical manufacturer. 02-Jul-2024 • Hemkesh Khattar. AI-generated image. Emcure Pharmaceuticals, a generic drug maker, is launching its IPO (initial public offering) on July 3, 2024. Below's a breakdown of the company's strengths, weaknesses, and growth ...
3 days ago · Emcure Pharma IPO:The initial public offering of Emcure Pharmaceuticals Ltd, which is backed by Bain Capital, will be opened for public subscription on July 3. The price band of the Rs 1,952-crore IPO, which will conclude on July 5, has been fixed at Rs 960-Rs 1,008 per share. Emcure Pharma IPO Allotment and Listing Dates.
